Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

Autor: J E, Meca-Lallana, M, Fernández-Prada, E, García Vázquez, S, Moreno Guillén, S, Otero Romero, M, Rus Hidalgo, L M, Villar Guimerans, S, Eichau Madueño, Ó, Fernández Fernández, G, Izquierdo Ayuso, J C, Álvarez Cermeño, C, Arnal García, R, Arroyo González, L, Brieva Ruiz, C, Calles Hernández, A, García Merino, M, González Plata, M Á, Hernández Pérez, E, Moral Torres, J, Olascoaga Urtaza, P, Oliva-Nacarino, C, Oreja-Guevara, R, Ortiz Castillo, A, Oterino, J M, Prieto González, L, Ramió-Torrentá, A, Rodríguez-Antigüedad, A, Saiz, M, Tintoré, X, Montalbán Gairin

Publikováno v: Scientia

Alemtuzumab; Eficacia; Práctica clínica habitual Alemtuzumab; Effectiveness; Daily clinical practice Alemtuzumab; Eficàcia; Pràctica clínica habitual Introduction Alemtuzumab is a highly effective drug approved by the European Medicines Agency a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5f910a7c2b129ab716f3d6f5dc7e6f8
https://doi.org/10.1016/j.nrleng.2019.11.001

IL-6-based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts

Autor: Alberto Utrero-Rico, Carmen Ayuso-García, Octavio Carretero, Javier Ruiz-Hornillos, Marta Corton, José María Aguado, Juan Carlos Taracido-Fernández, Antonio Herrero-González, Rocío Laguna-Goya, Berta Almoguera, Claudia Geraldine Rita, Rosario López-Rodríguez, L M Villar, Cecilia González-Cuadrado, Estela Paz-Artal, Pablo Minguez, Mario Fernández-Ruiz

Publikováno v: DDFV: Repositorio Institucional de la Universidad Francisco de Vitoria
Universidad Francisco de Vitoria
The Journal of Allergy and Clinical Immunology
DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname

Background Coronavirus disease 2019 (COVID-19) is a highly variable condition. Validated tools to assist in the early detection of patients at high risk of mortality can help guide medical decisions. Objective To validate externally, as well as in pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c5b370276352e964afa733f9bb196f
https://pubmed.ncbi.nlm.nih.gov/33662370

High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

Autor: Javier Zamora, Alfonso Muriel, Álvaro Beltrán-Corbellini, Luis Manzano, Enric Monreal, Susana Sainz de la Maza, Jesús Fortún, Araceli Alonso-Canovas, Elena Natera-Villalba, Lucienne Costa-Frossard, Paulette Esperanza Walo-Delgado, Jose Ignacio Fernández-Velasco, Beatriz Montero-Errasquín, Jaime Masjuan, L M Villar, Fernando Rodríguez-Jorge

Publikováno v: European Journal of Clinical Microbiology & Infectious Diseases

Despite the increasing evidence of the benefit of corticosteroids for the treatment of moderate-severe coronavirus disease 2019 (COVID-19) patients, no data are available about the potential role of high doses of steroids for these patients. We evalu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cbdd04eda2a7ad9d68fabf91367964c

Neurofilament light chain levels in pregnant multiple sclerosis patients: a prospective cohort study

Autor: J I Fernández Velasco, H Goicochea Briceño, S Medina Heras, Jens Kuhle, F Romero Delgado, S. Garcia-Tizon Larroca, M.L. Martínez Ginés, A Lozano Ros, R Álvarez Lafuente, Maria Inmaculada Dominguez-Mozo, Alfonso Muriel, Juan Pablo Cuello, L M Villar, Yolanda Higueras, Zuzanna Michalak, J. De Leon-Luis, Amalia Tejeda-Velarde, J. M. García Domínguez, C. de Andrés, A Meldaña Rivera, Christian Barro

Publikováno v: European journal of neurology. 26(9)

Background and purpose Neurofilament light chain is a cytoskeletal protein of neurons. Its levels are increasingly recognized as measures of neuroaxonal damage. The aim of this study was to explore serum neurofilament light chain (sNfL) levels in mul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d31c2711bc9f57c6e0ab8cb994a00a2
https://pubmed.ncbi.nlm.nih.gov/30977955

Laboratory guidelines for the diagnosis of patients with cryoglobulinaemic syndrome

Autor: A, Mariscal-Rodríguez, L M, Villar Guimerans, M, López-Trascasa, M, Hernández González, E, Moga Naranjo

Publikováno v: Revista clinica espanola. 219(9)

Cryoglobulinaemic syndromes include a collection of manifestations that are found in various diseases and that share a pathophysiological mechanism: cryoglobulin deposit in vascular beds. For these syndromes, the presence of cryoglobulins is a diagno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4693e0dc41146d6ee661a27468906e62
https://pubmed.ncbi.nlm.nih.gov/30577994